Jennifer A. Juno

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

David S. Khoury, Deborah Cromer, Arnold Reynaldi et al. · Nature Medicine · 2021 · 4.2K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection

Chansavath Phetsouphanh, D.R. Darley, Daniel B. Wilson et al. · Nature Immunology · 2022 · 1K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19

Jennifer A. Juno, Hyon‐Xhi Tan, Wen Shi Lee et al. · Nature Medicine · 2020 · 490 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19

Adam K. Wheatley, Jennifer A. Juno, Jing Jing Wang et al. · Nature Communications · 2021 · 410 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine

Yi Ju, Wen Shi Lee, Emily H. Pilkington et al. · ACS Nano · 2022 · 333 citations

Veterinary Medicine, Immunology, Infectious Diseases +17